Key Market Indicators
**Vaccination Coverage in Italy Forecasted to Remain Steady by 2028** Italy’s vaccination coverage for children aged one year old is projected to reach 93% by 2028, a slight dip from the current 94% in 2023. This figure indicates a consistent average rate with no significant change observed. Since 2005, the vaccination coverage rate has decreased marginally by 0.2 percentage points year on year. From a broader historical perspective, the vaccination coverage for the same age group is expected to maintain a 95% rate from 2023 to 2028, showing no change in the compound annual growth rate (CAGR) since 1988. **Vaccine Export and Import Trends** Italy’s vaccine export market is anticipated to grow significantly. By 2028, exports are projected to reach approximately $1.4 billion, up from $1.2 billion in 2023. This represents an average annual growth rate of 2.3%. Historically, since 1999, Italy’s vaccine supply has increased by an average of 5.5% per year. In 2023, Italy ranked as the sixth-largest vaccine exporter, with the United States leading the way. Belgium, the United Kingdom, and France held the second, third, and fourth positions, respectively. On the import side, Italy is expected to see its vaccine imports rise to roughly $797 million by 2028, up from $689 million in 2023. This reflects an average annual growth rate of 2.2%. Since 1999, Italy’s demand for imported vaccines has grown at the same rate of 2.2% per year. These trends highlight Italy's stable position in the global vaccine market, both as an exporter and importer, with consistent growth forecasted over the next five years.
